Logo image of ONWD.BR

ONWARD MEDICAL (ONWD.BR) Stock Fundamental Analysis

Europe - EBR:ONWD - NL0015000HT4 - Common Stock

4.26 EUR
+0.21 (+5.32%)
Last: 11/17/2025, 10:53:06 AM
Fundamental Rating

2

ONWD gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 60 industry peers in the Health Care Equipment & Supplies industry. The financial health of ONWD is average, but there are quite some concerns on its profitability. While showing a medium growth rate, ONWD is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ONWD has reported negative net income.
In the past year ONWD has reported a negative cash flow from operations.
ONWD had negative earnings in each of the past 5 years.
ONWD had a negative operating cash flow in each of the past 5 years.
ONWD.BR Yearly Net Income VS EBIT VS OCF VS FCFONWD.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

ONWD has a worse Return On Assets (-68.52%) than 91.67% of its industry peers.
ONWD has a worse Return On Equity (-139.43%) than 86.67% of its industry peers.
Industry RankSector Rank
ROA -68.52%
ROE -139.43%
ROIC N/A
ROA(3y)-57.55%
ROA(5y)-69.28%
ROE(3y)-112.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ONWD.BR Yearly ROA, ROE, ROICONWD.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150 -200

1.3 Margins

The Gross Margin of ONWD (77.16%) is better than 86.67% of its industry peers.
The Profit Margin and Operating Margin are not available for ONWD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 77.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ONWD.BR Yearly Profit, Operating, Gross MarginsONWD.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -10K -20K -30K -40K -50K

More info and screens

4

2. Health

2.1 Basic Checks

ONWD does not have a ROIC to compare to the WACC, probably because it is not profitable.
ONWD has more shares outstanding than it did 1 year ago.
ONWD has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ONWD has an improved debt to assets ratio.
ONWD.BR Yearly Shares OutstandingONWD.BR Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ONWD.BR Yearly Total Debt VS Total AssetsONWD.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

ONWD has an Altman-Z score of -2.41. This is a bad value and indicates that ONWD is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -2.41, ONWD is doing worse than 81.67% of the companies in the same industry.
ONWD has a Debt/Equity ratio of 0.52. This is a neutral value indicating ONWD is somewhat dependend on debt financing.
ONWD has a Debt to Equity ratio of 0.52. This is in the lower half of the industry: ONWD underperforms 65.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF N/A
Altman-Z -2.41
ROIC/WACCN/A
WACC7.58%
ONWD.BR Yearly LT Debt VS Equity VS FCFONWD.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 4.34 indicates that ONWD has no problem at all paying its short term obligations.
With an excellent Current ratio value of 4.34, ONWD belongs to the best of the industry, outperforming 95.00% of the companies in the same industry.
A Quick Ratio of 4.30 indicates that ONWD has no problem at all paying its short term obligations.
The Quick ratio of ONWD (4.30) is better than 98.33% of its industry peers.
Industry RankSector Rank
Current Ratio 4.34
Quick Ratio 4.3
ONWD.BR Yearly Current Assets VS Current LiabilitesONWD.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

4

3. Growth

3.1 Past

ONWD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.33%, which is quite impressive.
ONWD shows a strong growth in Revenue. In the last year, the Revenue has grown by 236.76%.
EPS 1Y (TTM)20.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.98%
Revenue 1Y (TTM)236.76%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

ONWD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.31% yearly.
ONWD is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 148.02% yearly.
EPS Next Y-16.81%
EPS Next 2Y-7.04%
EPS Next 3Y15.31%
EPS Next 5YN/A
Revenue Next Year426.67%
Revenue Next 2Y290.53%
Revenue Next 3Y251.99%
Revenue Next 5Y148.02%

3.3 Evolution

ONWD.BR Yearly Revenue VS EstimatesONWD.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M
ONWD.BR Yearly EPS VS EstimatesONWD.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ONWD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ONWD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ONWD.BR Price Earnings VS Forward Price EarningsONWD.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ONWD.BR Per share dataONWD.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

ONWD's earnings are expected to grow with 15.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-7.04%
EPS Next 3Y15.31%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ONWD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ONWARD MEDICAL

EBR:ONWD (11/17/2025, 10:53:06 AM)

4.26

+0.21 (+5.32%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)09-02 2025-09-02
Earnings (Next)N/A N/A
Inst Owners30.01%
Inst Owner ChangeN/A
Ins Owners16.06%
Ins Owner ChangeN/A
Market Cap190.46M
Revenue(TTM)1.11M
Net Income(TTM)-38.65M
Analysts87.27
Price Target12.63 (196.48%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.21%
PT rev (3m)-7.61%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)2.34%
EPS NY rev (3m)3.25%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.96%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 171.28
P/FCF N/A
P/OCF N/A
P/B 6.87
P/tB 10.31
EV/EBITDA N/A
EPS(TTM)-0.87
EYN/A
EPS(NY)-1.04
Fwd EYN/A
FCF(TTM)-0.81
FCFYN/A
OCF(TTM)-0.8
OCFYN/A
SpS0.02
BVpS0.62
TBVpS0.41
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -68.52%
ROE -139.43%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 77.16%
FCFM N/A
ROA(3y)-57.55%
ROA(5y)-69.28%
ROE(3y)-112.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 37.34%
Cap/Sales 31.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.34
Quick Ratio 4.3
Altman-Z -2.41
F-Score6
WACC7.58%
ROIC/WACCN/A
Cap/Depr(3y)43.86%
Cap/Depr(5y)180.36%
Cap/Sales(3y)362.35%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.98%
EPS Next Y-16.81%
EPS Next 2Y-7.04%
EPS Next 3Y15.31%
EPS Next 5YN/A
Revenue 1Y (TTM)236.76%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year426.67%
Revenue Next 2Y290.53%
Revenue Next 3Y251.99%
Revenue Next 5Y148.02%
EBIT growth 1Y-1.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-26.11%
EBIT Next 3Y14.21%
EBIT Next 5YN/A
FCF growth 1Y-7.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-8.63%
OCF growth 3YN/A
OCF growth 5YN/A

ONWARD MEDICAL / ONWD.BR FAQ

Can you provide the ChartMill fundamental rating for ONWARD MEDICAL?

ChartMill assigns a fundamental rating of 2 / 10 to ONWD.BR.


What is the valuation status for ONWD stock?

ChartMill assigns a valuation rating of 0 / 10 to ONWARD MEDICAL (ONWD.BR). This can be considered as Overvalued.


What is the profitability of ONWD stock?

ONWARD MEDICAL (ONWD.BR) has a profitability rating of 1 / 10.